Cargando…
Chaperone-Based Therapies for Disease Modification in Parkinson's Disease
Parkinson's disease (PD) is the second most common neurodegenerative disorder and is characterized by the presence of pathological intracellular aggregates primarily composed of misfolded α-synuclein. This pathology implicates the molecular machinery responsible for maintaining protein homeosta...
Autores principales: | Friesen, Erik L., De Snoo, Mitch L., Rajendran, Luckshi, Kalia, Lorraine V., Kalia, Suneil K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585656/ https://www.ncbi.nlm.nih.gov/pubmed/28913005 http://dx.doi.org/10.1155/2017/5015307 |
Ejemplares similares
-
Regulation of Parkin-dependent mitophagy by Bcl-2-associated athanogene (BAG) family members
por: Kapadia, Minesh, et al.
Publicado: (2020) -
LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
por: O’Hara, Darren M., et al.
Publicado: (2020) -
BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62
por: Friesen, Erik L., et al.
Publicado: (2020) -
Predictors of Future Deep Brain Stimulation Surgery in de novo Parkinson's Disease
por: Lang, Stefan, et al.
Publicado: (2023) -
Merging DBS with viral vector or stem cell implantation: “hybrid” stereotactic surgery as an evolution in the surgical treatment of Parkinson’s disease
por: Rowland, Nathan C, et al.
Publicado: (2016)